<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04760756</url>
  </required_header>
  <id_info>
    <org_study_id>REC/0045 Anam Aftab</org_study_id>
    <nct_id>NCT04760756</nct_id>
  </id_info>
  <brief_title>The Effects of Fragility Fracture Integrated Rehabilitation Management</brief_title>
  <official_title>The Effects of Fragility Fracture Integrated Rehabilitation Management (FIRM) of Hip Fracture in Geriatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zohra Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zohra Institute of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      â€¢ To determine the effects of Fragility Fracture Integrated Rehabilitation Management&#xD;
      approach in geriatric hip fracture patients (post surgical)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This refers to Fragility Fracture Integrated Rehabilitation Management and will include&#xD;
      following comprehensive rehabilitation program including rehab specialist, physiotherapist,&#xD;
      occupational therapist and rehab nurse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Ambulatory Category (FAC)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The Functional Ambulation Categories (FAC) is a functional walking test that evaluates ambulation ability. This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ-5D</measure>
    <time_frame>2 weeks</time_frame>
    <description>EQ-5D is a standardized instrument for measuring generic health status. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Barthel index (MBI)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Modified Barthel ADL index Measure of physical disability used widely to assess behaviour relating to activities of daily living for patients with disabling conditions. It measures what patients do in practice.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hip Fractures</condition>
  <arm_group>
    <arm_group_label>This refers to Fragility Fracture Integrated Rehabilitation Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This refers to Fragility Fracture Integrated Rehabilitation Management and will include comprehensive rehabilitation program and assessment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fragility Fracture Integrated Rehabilitation Management</intervention_name>
    <description>At least 2 hours of rehabilitation management per day&#xD;
Including occupational therapy (training to improve daily life performance)&#xD;
Inpatient (the first 2 weeks): daily management (body control ability, mobility ability, hygiene management, etc.)&#xD;
Outpatient (2-6 weeks): management once a week&#xD;
The management period is for 2 weeks (1 week after surgery)</description>
    <arm_group_label>This refers to Fragility Fracture Integrated Rehabilitation Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients above 55 years of age, who underwent hip fracture management NIRM Pakistan&#xD;
             due to hip fracture&#xD;
&#xD;
          2. Patient diagnosed with femur neck, intertrochanteric fracture, and sub-trochanteric&#xD;
             fracture&#xD;
&#xD;
          3. Patient who got bipolar hemiarthroplasty, total hip replacement arthroplasty,&#xD;
             reduction and internal fixation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who underwent surgery for a cause other than a hip fracture (infection,&#xD;
             arthritis, loosening, avascular necrosis)&#xD;
&#xD;
          2. Patients who underwent surgery because of femur shaft fracture, acetabular fracture,&#xD;
             periprosthetic fracture pathologic fracture by tumor&#xD;
&#xD;
          3. Isolated fracture of the greater or lesser tuberosity&#xD;
&#xD;
          4. Multiple fracture&#xD;
&#xD;
          5. Revision operation&#xD;
&#xD;
          6. Patients who do not agree to participate in clinical trials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anam Aftab, Phd*</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riphah college of rehabilitation and allied health sciences - Rawalpindi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shaista Habibullah, PhD</last_name>
    <phone>03362291027</phone>
    <email>shaista.habibullah2014@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Institute of Rehabilitation Medicine</name>
      <address>
        <city>Islamabad</city>
        <zip>0042</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaista Habibullah, Phd</last_name>
      <phone>03362291027</phone>
      <email>shaista.habibullah2014@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Boschitsch EP, Durchschlag E, Dimai HP. Age-related prevalence of osteoporosis and fragility fractures: real-world data from an Austrian Menopause and Osteoporosis Clinic. Climacteric. 2017 Apr;20(2):157-163. doi: 10.1080/13697137.2017.1282452. Epub 2017 Feb 8.</citation>
    <PMID>28286986</PMID>
  </reference>
  <reference>
    <citation>Nanes MS, Kallen CB. Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis. Fertil Steril. 2009 Aug;92(2):403-12. doi: 10.1016/j.fertnstert.2009.05.049. Epub 2009 Jun 25. Review.</citation>
    <PMID>19559412</PMID>
  </reference>
  <reference>
    <citation>Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994 Aug;9(8):1137-41.</citation>
    <PMID>7976495</PMID>
  </reference>
  <reference>
    <citation>Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010 Nov-Dec;16 Suppl 3:1-37.</citation>
    <PMID>21224201</PMID>
  </reference>
  <reference>
    <citation>Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, Helms PJ, Seaton A, Weiss ST. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007 Mar;85(3):853-9.</citation>
    <PMID>17344509</PMID>
  </reference>
  <reference>
    <citation>Khan K, Brown J, Way S, Vass N, Crichton K, Alexander R, Baxter A, Butler M, Wark J. Overuse injuries in classical ballet. Sports Med. 1995 May;19(5):341-57. Review.</citation>
    <PMID>7618011</PMID>
  </reference>
  <reference>
    <citation>Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253. Erratum in: J Bone Miner Res. 2011 Aug;26(8):1987.</citation>
    <PMID>20842676</PMID>
  </reference>
  <reference>
    <citation>Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):671-85. doi: 10.1016/j.beem.2008.06.001. Review.</citation>
    <PMID>19028351</PMID>
  </reference>
  <reference>
    <citation>Shepstone L, Fordham R, Lenaghan E, Harvey I, Cooper C, Gittoes N, Heawood A, Peters T, O'Neill T, Torgerson D, Holland R, Howe A, Marshall T, Kanis J, McCloskey E. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Osteoporos Int. 2012 Oct;23(10):2507-15.</citation>
    <PMID>22314936</PMID>
  </reference>
  <reference>
    <citation>Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008 Apr;19(4):385-97. doi: 10.1007/s00198-007-0543-5. Epub 2008 Feb 22.</citation>
    <PMID>18292978</PMID>
  </reference>
  <reference>
    <citation>Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208. Review.</citation>
    <PMID>3902494</PMID>
  </reference>
  <reference>
    <citation>Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995 Nov;17(5 Suppl):505S-511S. Review.</citation>
    <PMID>8573428</PMID>
  </reference>
  <reference>
    <citation>Bukata SV, Digiovanni BF, Friedman SM, Hoyen H, Kates A, Kates SL, Mears SC, Mendelson DA, Serna FH Jr, Sieber FE, Tyler WK. A guide to improving the care of patients with fragility fractures. Geriatr Orthop Surg Rehabil. 2011 Jan;2(1):5-37. doi: 10.1177/2151458510397504.</citation>
    <PMID>23569668</PMID>
  </reference>
  <reference>
    <citation>Coleman EA. Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc. 2003 Apr;51(4):549-55. Review.</citation>
    <PMID>12657078</PMID>
  </reference>
  <reference>
    <citation>Kates SL, Mendelson DA, Friedman SM. Co-managed care for fragility hip fractures (Rochester model). Osteoporos Int. 2010 Dec;21(Suppl 4):S621-5. doi: 10.1007/s00198-010-1417-9. Epub 2010 Nov 6.</citation>
    <PMID>21058002</PMID>
  </reference>
  <reference>
    <citation>Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention; American Heart Association Council on Nutrition, Physical Activity, and Metabolism Subcommittee on Physical Activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003 Jun 24;107(24):3109-16.</citation>
    <PMID>12821592</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zohra Institute of Health Sciences</investigator_affiliation>
    <investigator_full_name>Aftab</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Activities of daily living</keyword>
  <keyword>Mobility limitation</keyword>
  <keyword>Occupational Therapy</keyword>
  <keyword>Physical Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

